In our second installment in a series, we discuss how the K-GMP certificate is an integral step to entering the market in South Korea.
In this first in a series of regulatory articles, we give an update on the medical device regulatory system in South Korea.
MHRA confirmed they will adopt the risk categorization in IMDRF: "Software as a Medical Device": Possible Framework for Risk Categorization and Corresponding Considerations.
Here we at Emergo by UL give an update on the current state of global adverse event coding.
In this on-demand webinar, our Emergo by UL subject matter expert outlines the latest insights about U.S. FDA Pre-Submissions.
The UK medical device regulator MHRA presented a webinar (March 5) on the upcoming changes to the medical devices legislation for Great Britain.
This summarizes our In-house Devices per European IVDR Webinar and includes impending deadlines and questions posed during the session.
In this on-demand webinar, our Emergo by UL subject matter expert navigates through current regulatory requirements under IVDR.
The FDA reminds device manufacturers and medical device study sponsors to cautiously select third-party laboratories for verification and validation testing.
Manufacturers can better understand quality and regulatory issues of concern by the U.S. Food and Drug Administration (FDA) by reviewing relevant warning letters. This can allow companies to focus on problem areas as they continually assess and improve their internal procedures and processes.